HIGHLIGHTS
- who: Farah Ballout and colleagues from the Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA have published the research work: Targeting NRF2 Sensitizes Esophageal Adenocarcinoma Cells to Cisplatin through Induction of Ferroptosis and Apoptosis, in the Journal: Antioxidants 2022, 1859 of 10/05/2022
- what: The authors investigated the role of NRF2 in Barrett`s related esophageal adenocarcinoma and determined the potential therapeutic efficacy of targeting NRF2 using Brusatol as a single agent and in combination with cisplatin. In the experiments , the authors utilized relatively low doses and demonstrated the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.